The audit, conducted by National Quality Assurance, evaluated the company’s quality system that supports its molecular diagnostic services and early assay development for cancer biomarkers.
Insight Genetics chairman and CEO Eric Dahlhauser said the company provides the highest quality services to its customers and partners.
"This certification demonstrates the rigorous quality standards we uphold in our lab and underscores our commitment to physicians caring for those with cancer and to drug developers advancing treatments available to these patients," Dahlhauser added.